USPTO serial 87581720
SEFACOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 27, 2018
- Examiner
- KOVALSKY, LAURA G
- Law office
- Historical data usage
What this means
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
Need help with SEFACOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Somerville, MA
Somerville, MA
Somerville, MA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research in the field of natural resources; Research on the subject of pharmaceuticals; Analysis for oil research; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research services; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies | ACTIVE | Apr 28, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 5, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Sep 5, 2025 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Sep 5, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Apr 7, 2025 | PRA8 | POST REGISTRATION ACTION MAILED - SEC. 8 | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 23, 2024 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Mar 27, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 27, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 9, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 9, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 20, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 30, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 30, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2017 | NWAP | NEW APPLICATION ENTERED | — |